Efficacy and safety of interventions to control myopia progression in children: an overview of systematic reviews and meta-analyses Post date November 16, 2022 ← Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control → Low-Concentration Atropine Eye Drops for Myopia Progression
